当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析

亿帆医药

(002019)

  

流通市值:126.31亿  总市值:182.58亿
流通股本:8.41亿   总股本:12.16亿

亿帆医药(002019)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润2.84亿元,每股收益0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益865672.75万元,未分配利润465042.13万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1267413.99万元,负债401741.24万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,635,110,083.181,326,616,043.25,159,823,227.643,858,211,534.78
营业总成本2,316,453,207.971,200,723,203.714,758,180,864.673,531,892,029.96
其他经营收益
营业利润342,945,947.22157,061,740.52381,810,182.55383,633,544.49
利润总额344,324,147.92156,682,698.91388,656,952.28385,056,800.16
净利润284,158,135.82138,229,631.62323,621,712.62307,759,997.51
每股收益
其他综合收益61,055,565.2820,675,101.78-25,329,608.54-10,825,241.37
综合收益总额345,213,701.1158,904,733.4298,292,104.08296,934,756.14
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,967,724,843.293,901,724,271.73,778,271,166.023,926,109,338.7
非流动资产:
非流动资产合计8,706,415,052.418,609,163,489.228,507,516,922.738,443,649,535.01
资产总计12,674,139,895.712,510,887,760.9212,285,788,088.7512,369,758,873.71
流动负债:
流动负债合计3,032,692,512.762,848,616,568.822,987,056,324.92,983,756,561.36
非流动负债:
非流动负债合计984,719,837.91,074,410,314.42871,936,425.87966,649,366.68
负债合计4,017,412,350.663,923,026,883.243,858,992,750.773,950,405,928.04
所有者权益(或股东权益):
归属于母公司股东权益合计8,771,392,564.728,697,424,767.688,521,867,867.568,512,990,128.59
股东权益合计8,656,727,545.048,587,860,877.688,426,795,337.988,419,352,945.67
负债和股东权益合计12,674,139,895.712,510,887,760.9212,285,788,088.7512,369,758,873.71
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,774,636,043.071,411,616,036.125,327,126,585.644,113,720,104.84
经营活动现金流出小计2,488,538,971.841,229,280,618.834,686,396,392.993,760,310,480.77
经营活动产生的现金流量净额286,097,071.23182,335,417.29640,730,192.65353,409,624.07
投资活动产生的现金流量:
投资活动现金流入小计89,287,620.183,820,416799,738,546.37482,394,728.4
投资活动现金流出小计248,329,030.27111,178,114.141,344,617,424.66851,092,400.39
投资活动产生的现金流量净额-159,041,410.09-107,357,698.14-544,878,878.29-368,697,671.99
筹资活动产生的现金流量:
筹资活动现金流入小计745,685,562.04517,987,185.772,036,620,186.41,731,435,846.91
筹资活动现金流出小计893,098,804.57604,361,616.451,923,888,466.071,386,793,199.51
筹资活动产生的现金流量净额-147,413,242.53-86,374,430.68112,731,720.33344,642,647.4
汇率变动对现金及现金等价物的影响15,504,362.212,144,060.32-3,691,057.98-2,338,325.28
现金及现金等价物净增加额-4,853,219.18-9,252,651.21204,891,976.71327,016,274.2
期末现金及现金等价物余额772,784,638.72768,385,206.69777,637,857.9899,762,155.39
补充资料:
现金及现金等价物的净增加额-4,853,219.18-204,891,976.71-
最新报告期:2025-09-04
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通0.520.660.812025-09-04
太平洋周豫0.490.660.832025-08-28
首创证券王斌0.490.660.822025-08-27
西南证券杜向阳0.490.650.772025-08-25
华安证券谭国超0.490.580.692025-08-23
TOP↑